SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-25-004455
Filing Date
2025-01-10
Accepted
2025-01-10 16:10:43
Documents
15
Period of Report
2025-01-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d778635d8k.htm   iXBRL 8-K 32151
2 EX-99.1 d778635dex991.htm EX-99.1 8755
6 GRAPHIC g778635g0110111444468.jpg GRAPHIC 3780
  Complete submission text file 0001193125-25-004455.txt   170697

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA igms-20250107.xsd EX-101.SCH 2835
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE igms-20250107_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igms-20250107_pre.xml EX-101.PRE 10802
17 EXTRACTED XBRL INSTANCE DOCUMENT d778635d8k_htm.xml XML 3507
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39045 | Film No.: 25522968
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)